The methodology and evidence behind a widely publicized change in national mammography guidelines is questionable, according to a review in the Journal of Diagnostic Medical Sonography (JDMS), published by SAGE…
No Comments »
Filed under: Women's Health
MedImmune today announced that clinical results of its pivotal multinational, randomized, double-masked trial for motavizumab have been published in the current issue of the peer-reviewed publication, Pediatrics: Official Journal of the American Academy of Pediatrics.
No Comments »
Filed under: Pharmacy News
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled “Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom’s Macroglobulinemia,” reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the [...]
No Comments »
Filed under: Pharmacy News
Keryx Biopharmaceuticals, Inc. (the “Company”) today announced that an article entitled “Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom’s Macroglobulinemia,” reporting Phase 2 data demonstrating the single agent activity of KRX-0401 (Perifosine) for the treatment of advanced Waldenstrom’s Macroglobulinemia (”Waldenstrom’s”), will appear [...]
No Comments »
Filed under: Pharmacy News
New guidance published in the open access journal Trials and bmj.com this week sets out how personal information from clinical trials should be shared to help minimize risks to patient privacy.
No Comments »
Filed under: Pharmacy News
In her comments in today’s quarterly report Elisabeth Lindner, President and CEO of Diamyd Medical, says that the Company’s objective is to file the Diamyd® diabetes vaccine for market approval in 2011 - a goal that isn’t very far off now.
No Comments »
Filed under: Pharmacy News
Merge Healthcare has successfully deployed its etrials eDiary 5.0 platform to conduct a global Phase II urology clinical trial involving 750 patients for one of the largest pharmaceutical companies in the world. Merge was awarded the project because of its eDiary technology, experience in global ePRO (electronic patient reported outcomes) trials and ability to manage [...]
No Comments »
Filed under: Pharmacy News
The United States can lead the world in deploying advanced biotechnology for biofuels and create thousands of new jobs by implementing policies to support the emerging industry…
No Comments »
Filed under: Pharmacy News
The Biotechnology Industry Organization (BIO) announced today its newest conference, the Livestock Biotech Summit, scheduled for September 28-30, 2010, in Sioux Falls, S.D…
No Comments »
Filed under: Pharmacy News
Tibotec Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved a labeling update for PREZISTA® (darunavir) tablets to include 96-week data from the ARTEMIS and TITAN studies. Both ARTEMIS and TITAN evaluated the efficacy and safety of PREZISTA with ritonavir (r) vs…
No Comments »
Filed under: Pharmacy News
